Inspira Technologies Oxy BHN Ltd
Inspira Technologies Oxy BHN Ltd maintains a strong liquidity position, with $3.16 million in cash and equivalents, representing 59.1% of total assets. The company has no long-term debt and a current ratio of 1.56, indicating sufficient short-term liquidity to cover obligations. However, the firm reported negative operating and free cash flows of -$9.86 million and -$12.87 million, respectively, signaling ongoing operational cash burn. Profitability metrics are severely negative, with a net loss of $13.22 million and an operating loss of $13.62 million. Return on equity (ROE) and return on assets (ROA) are -5.69% and -2.48%, respectively, far below the industry median for advanced medical equipment firms. The company's price-to-book ratio of 8.38 and enterprise value-to-revenue ratio of 56.45 suggest a premium valuation relative to tangible asset base and revenue, despite unprofitable operations. The firm operates as a single-segment entity with no disclosed geographic revenue breakdown. This lack of diversification introduces concentration risk, as the company's performance is entirely dependent on its core product lines and regional demand. No material revenue concentration by geography or customer is reported in the latest filings. Growth prospects remain uncertain, with no revenue growth reported in the latest period. The company's operating losses and negative cash flows indicate a lack of scalable revenue generation. Analysts have assigned a mean price target of $5.00, implying a 1,000% upside from the current market price of $0.45, though this is based on a single "buy" recommendation with no supporting detail. Risk factors include liquidity risk from negative operating cash flows and dilution risk from potential future equity raises to fund operations. The firm has no immediate filing-based liquidity or dilution flags, but its capital structure shows no dilution in the current period (basic and diluted shares are equal). No adjustments were applied to valuation metrics, indicating clean financial reporting. Recent events include the publication of the latest financial snapshot, which shows continued operational losses and no material changes in capital structure. No recent filings, transcripts, or regulatory actions were identified in the available data.
Business. Inspira Technologies Oxy BHN Ltd designs, develops, and commercializes advanced medical equipment and technology solutions, primarily serving the healthcare services and equipment sector.
Classification. The company is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.
- Inspira Technologies Oxy BHN Ltd is a loss-making advanced medical equipment firm with a premium valuation despite negative cash flows and returns.
- The company's liquidity position is strong in absolute terms but unsustainable given ongoing operational cash burn.
- Analysts have assigned a high price target, but the recommendation is based on a single "buy" rating with no supporting detail.
- The firm's lack of geographic or segment diversification introduces concentration risk.
- No immediate liquidity or dilution flags are present, but future equity raises may be necessary to fund operations.
- --
- # RATIONALES
- ```json
- No immediate filing-based liquidity or dilution flags were detected.